Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹222.95 (-0.20%) as of
Key statistics
- Market cap
- 14.73B
- P/E (TTM)
- 33.23
- EPS (TTM)
- 6.71
- Dividend yield
- 1.12%
- 52-week range
- 154.90 – 264.65
- Beta
- -0.27
- Revenue (TTM)
- 2.94B
- Profit margin
- 15.48%
- Volume
- 1.90k
About Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Gurugram, India
- Employees
- 1,297
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.